The design of future healthcare should keep in mind sustainable innovation. Faster access to new medicines, an agile regulatory framework and robust IP incentives are all part of the EU’s future healthcare innovation ecosystem. In June, Europeans will elect a new European Parliament. Later, a new European Commission will be formed. Member States are starting to debate the proposed revision of the EU General Pharmaceutical Legislation at the Council of the EU. Much is at stake as we look to the future of European healthcare and industrial competitiveness. As part of a collaboration with Friends of Europe, Monica Shaw, SVP, Head of European Markets explores what sustainable healthcare innovation means for patients.